# CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
> **ANDA213269** · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARMA CANADA · Approved 2020-09-02
## Drug
- **FDA Application Number:** ANDA213269
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
- **Generic name:** CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
- **Active ingredients:** BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
- **Dosage form:** SUSPENSION
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** SUN PHARMA CANADA
- **Manufacturer:** Sun Pharmaceutical Industries, Inc.
- **First approval:** 2020-09-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213269)
---
*MORVS · CC0 1.0*